saypha volume Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic - ARTG 475367
Access comprehensive regulatory information for saypha volume Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 475367 and sponsored by AA-Med Pty Ltd, manufactured by Croma-Pharma GmbH in Austria. The device registration started on January 08, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The intended aesthetic purpose of saypha volume lidocaine is to add volume. It is indicated to correct moderate to severa nasolabial folds, and must be injected into the deep dermis, subctis or supraperiosteal tissue.